Liisa Ahtee | |
|---|---|
 1975 | |
| Born | 2 October 1937 |
| Nationality | Finnish |
| Occupation(s) | pharmacologist, professor |
| Years active | 1975–present |
Liisa Marjatta Ahtee was born on 2 October 1937 in Turku to Aaro Veli Vilho and Lyyli Iida Kyllikki Ahtee. [1] She is an internationally esteemed Finnish pharmacologist and professor emeritus, who served as pharmacology and biological medicine standardization chair at the University of Helsinki from 1975 to 2002. [2]
Ahtee graduated as a medical doctor in 1962 and defended her Ph.D. in Pharmacology at the University of Helsinki in 1967. From 1967 to 1969 she conducted scientific research [2] at the American Red Cross Institute of Animal Physiology [1] of Cambridge and from 1970–1971 [2] at the Royal College of Surgeons [1] in London before returning to Finland. In 1975 Ahtee was appointed as a professor and chair at the University of Helsinki in pharmacology and biological medical standardization divisions. In 1977 she conducted research at the University of Gothenburg in Sweden and in Paris in 1980. [2]
Ahtee's research specialization is neuropharmacology, concentrating on the effects of drugs and drug addiction on the central nervous system neurotransmitters. She has written hundreds of articles on her research findings and is considered an international expert. In addition to writing, Ahtee has been the editor of several international science journals, [2] including Naunyn-Schmiedeberg's Archives of Pharmacology. [1]
In 1999, she was the Albert Wuokko Award recipient, [2] an annual prize given to distinguished pharmaceutical scientists of Finland [3] and in 2003, she was awarded an honorary doctorate from Tartu University. [2]
Even after her retirement as a professor, Ahtee continued her research completing a three-year project in 2010 on the "brain opioidergic systems and neurobehavioral sensitization in addiction to alcohol". [4]
Drug tolerance or drug insensitivity is a pharmacological concept describing subjects' reduced reaction to a drug following its repeated use. Increasing its dosage may re-amplify the drug's effects; however, this may accelerate tolerance, further reducing the drug's effects. Drug tolerance is indicative of drug use but is not necessarily associated with drug dependence or addiction. The process of tolerance development is reversible and can involve both physiological factors and psychological factors.
Sensitization is a non-associative learning process in which repeated administration of a stimulus results in the progressive amplification of a response. Sensitization often is characterized by an enhancement of response to a whole class of stimuli in addition to the one that is repeated. For example, repetition of a painful stimulus may make one more responsive to a loud noise.
Reverse tolerance or drug sensitization is a pharmacological phenomenon describing subjects' increased reaction to a drug following its repeated use. Not all drugs are subject to reverse tolerance.
George F. Koob is a Professor and former Chair of the Committee on the Neurobiology of Addictive Disorders at the Scripps Research Institute and Adjunct Professor of Psychology, Psychiatry, and Skaggs School of Pharmacy and Pharmaceutical Sciences at the University of California, San Diego. In 2014 he became the director of the National Institute on Alcohol Abuse and Alcoholism.
Barry John Everitt, is a British neuroscientist and academic. He was Master of Downing College, Cambridge (2003–2013), and Professor of Behavioural Neuroscience at the University of Cambridge (1997–2013). He is now emeritus professor and Director of Research. From 2013 to 2022, he was provost of the Gates Cambridge Trust at Cambridge University.
Bertha Kalifon Madras is a professor of psychobiology in the Department of Psychiatry and the chair of the Division of Neurochemistry at Harvard Medical School, Harvard University. She served as associate director for public education in the division on Addictions at Harvard Medical School. Madras has published research in the areas of drug addiction, ADHD, and Parkinson's disease.
Trevor William RobbinsCBE FRS FMedSci is a professor of cognitive neuroscience and the former Head of the Department of Psychology at the University of Cambridge. Robbins interests are in the fields of cognitive neuroscience, behavioural neuroscience and psychopharmacology.
Behavioral addiction, process addiction, or non-substance-related disorder is a form of addiction that involves a compulsion to engage in a rewarding non-substance-related behavior – sometimes called a natural reward – despite any negative consequences to the person's physical, mental, social or financial well-being. In the brain's reward system, a gene transcription factor known as ΔFosB has been identified as a necessary common factor involved in both behavioral and drug addictions, which are associated with the same set of neural adaptations.
Addiction is a neuropsychological disorder characterized by a persistent and intense urge to use a drug or engage in a behaviour that produces natural reward, despite substantial harm and other negative consequences. Repetitive drug use often alters brain function in ways that perpetuate craving, and weakens self-control. This phenomenon – drugs reshaping brain function – has led to an understanding of addiction as a brain disorder with a complex variety of psychosocial as well as neurobiological factors that are implicated in addiction's development. Classic signs of addiction include compulsive engagement in rewarding stimuli, preoccupation with substances or behavior, and continued use despite negative consequences. Habits and patterns associated with addiction are typically characterized by immediate gratification, coupled with delayed deleterious effects.
A psychoactive drug, psychopharmaceutical, psychoactive agent, or psychotropic drug is a chemical substance that changes the function of the nervous system and results in alterations of perception, mood, cognition, and behavior. These substances may be used medically, recreationally, for spiritual reasons, or for research. Some categories of psychoactive drugs may be prescribed by physicians and other healthcare practitioners because of their therapeutic value.
Susan G. Amara is an American professor of neuroscience and is the Scientific Director of the National Institute of Mental Health. Dr. Amara is an elected member of the National Academy of Sciences and a fellow of the American Association for the Advancement of Science. She is a Past-President of the Society for Neuroscience. Dr. Amara has a B.S. in Biological Sciences from Stanford University and a Ph.D. in Physiology and Pharmacology from the University of California, San Diego.
Charles P. O'Brien is a research scientist, medical educator and a leading expert in the science and treatment of addiction. He is board certified in neurology, psychiatry and addiction psychiatry. He is currently the Kenneth E. Appel Professor of Psychiatry, and vice chair of psychiatry, in the Perelman School of Medicine at the University of Pennsylvania.
Dr. Brigitte Kieffer is a French molecular neurobiologist known for her research of opiate receptors. Her areas of expertise include: molecular psychiatry, addiction, mood disorders, pain, and developmental disorders. Kieffer has international reputation in the field of opiate receptors, and has paved the way for better understanding of brain mechanisms involved in pain, mental illness, and drug addiction. She continues to pursue research and directs a team of over 300 people. Her discoveries have shed light on how substances like morphine or heroin can kill pain, and foster addiction.
Patricia Janak is a Bloomberg Distinguished Professor at Johns Hopkins University who studies the biological basis of behavior through associative learning. Janak applies this research to pathological behaviors, such as addiction and posttraumatic stress disorder, to improve understanding of how stimuli affect relapse and responses.
Nancy Rutledge Zahniser was an American pharmacologist, best known for her work involving the mechanism of dopaminergic pathways and chemical modifications of them. Although born in Ann Arbor, Michigan, Zahniser grew up in Chillicothe, Ohio and subsequently enrolled at the College of Wooster, where she obtained a degree in chemistry. After completing her degree, Zahniser spent some time in India where she met her first husband Mark Zahniser; she later returned to the United States to attend the University of Pittsburgh School of Pharmacy, where she earned her PhD in pharmacology in 1977. Zahniser went on to complete her post-doctoral training at the University of Colorado Health Sciences Center's Department of Pharmacology and then became a part of the faculty there. In 2007, she became associate dean for research education. She played a role in advancing the careers of many post-doctoral students in her lab. In addition to her work as a professor, Zahniser was also a member of several boards, committees, review panels, and professional societies related to pharmacology, neuroscience, and addiction. She led several national research meetings from 1995-2002.
Dr. Dolores C. Shockley was the first black woman to receive a PhD in pharmacology in the United States and one of the first African American students to receive a PhD from Purdue University. After obtaining her PhD she became faculty at the historically black school Meharry Medical College where she subsequently became the first black woman to chair a Pharmacology department in the United States in 1988. Her research contributions included studying the effects of chemical pollutants on the brain and identifying pharmacological agents that interact with drugs of abuse such as cocaine. She was a distinguished scholar and emeritus professor at Meharry Medical College.
Marina Elizabeth Wolf is an American neuroscientist and Professor of Behavioral Neuroscience at Oregon Health & Science University. Previously she served as Professor and Chair of the Department of Neuroscience in the Chicago Medical School at Rosalind Franklin University of Medicine and Science. She has been a pioneer in studying the role of neuronal plasticity in drug addiction. Her laboratory is particularly interested in understanding why individuals recovering from substance use disorder remain vulnerable to drug craving and relapse even after long periods of abstinence.
Colleen Ann McClung is an American chronobiologist and neuroscientist. She is a professor at the University of Pittsburgh and a fellow of the American College of Neuropsychopharmacology.
Terry Earl Robinson is a biopsychologist and neuroscientist, and the Elliot S. Valenstein Distinguished University Professor of Psychology & Neuroscience at The University of Michigan.
Dora B. Goldstein, nicknamed Dody, was a pharmacologist and professor who researched the effects of ethanol on the body and the biochemistry of alcohol addiction and alcohol withdrawal syndrome. A Bay Stater, she studied medicine at Bryn Mawr College and Harvard Medical School, with an interruption during World War II to help the war effort, before joining the faculty at Stanford University in the 1950's. Becoming a tenured professor of pharmacology, she was well known for her research and classes keeping on the edge of new biochemical visualization technologies into the 1980's, along with her efforts to promote the advancement of women in science at the university.
| International | |
|---|---|
| National | |
